An impending three-week trial for the Robodebt class action may be in danger due to stage 4 lockdown measures in place in Victoria to control a second wave of coronavirus cases, with the top lawyer for the class telling the court he might need to step down due to homeschooling obligations if the lockdown overlaps with the trial.
A class action investigation has been launched against the Victoria state government and private contractors over alleged failures in the state’s hotel quarantine program believed to be responsible for its second wave of coronavirus cases.
Law firm Norton Rose Fulbright has warned of a serious risk of industry-wide class actions against the aged care sector over its handling of COVID-19, but if the largest plaintiffs law firms are planning litigation they are keeping their cards close to their chest.
An error in an opt out notice sent to motorists eligible to sign up for a class action over allegedly defective diesel filters in Toyota vehicles has left a class action law firm on the hook for indemnity costs to cover a new notice to group members.
A former QRx Pharma director’s prediction that shareholders would not receive “anything of consequence” from a class action settlement has proven true, with only a small slice of the $7 million settlement expected to go to shareholders.
Insurance policies that may be worth up to $46 million and have derailed settlement approval in two class actions against sandalwood producer Quintis were “cobbled together” and contained errors and omissions, a court has heard.
Two competing shareholder class actions against global winemaker and distributor Treasury Wine Estates over an earnings downgrade in January this year should be consolidated, and a judge should pick just one law firm to run the case, a court has heard.
AMP, Commonwealth Bank and Westpac are facing potential class actions over commissions grandfathered by the FoFA reforms and the firms alleged failure to protect client interests.
Communications and technical services company BSA Limited has slammed as “opportunistic” an employment class action by allegedly underpaid technicians, saying the media was informed of the proceedings before it was.
ASX-listed generic drug maker Mayne Pharma is facing a possible shareholder class action over disclosures related to US price-fixing allegations against the ASX-listed company.